Friedreich's ataxia (FRDA) is a rare inherited neuro-and cardio-degenerative disease caused by reduced levels of the mitochondrial protein frataxin [1] . The metabolic defect in FRDA leads to mitochondrial iron loading that results from deregulation of three major pathways of mitochondrial iron metabolism: iron-sulfur cluster (ISC) biosynthesis, haem biogenesis and mitochondrial iron storage [2] . Additionally, it is thought that abnormally deposited iron within mitochondria promotes Fenton chemistry and thus contributes to toxic free radical production that exacerbates cellular dysfunction [1] . Modulation of these processes by frataxin appears to be crucial for cell survival, as frataxin deficiency leads to cell death in affected tissues [1] .
Although the exact molecular functions of frataxin remain unknown, there is an emerging general consensus that iron binding by the protein may be important for its proposed roles in the regulation of mitochondrial iron metabolism ( Figure 1 ). One such emerging role for frataxin is as an iron chaperone or 'donor' that interacts with its various binding partners, in an iron-dependent manner, to facilitate ISC and haem biosynthesis [1] . In support of this notion, yeast frataxin (Yfh1) appears to interact with the central ISC assembly complex [consisting of the scaffolding protein (Isu) and the cysteine desulfurase (Nfs1)] in a manner that is strongly enhanced by physiological concentrations of ferrous iron [1] . Similarly, interaction of human frataxin with either Isu or ferrochelatase of the haem-biosynthetic pathway appears to be iron-dependent [1] . An intriguing recent study on the bacterial frataxin orthologue, CyaY, suggests that frataxins may not be iron chaperones as such, but may function as iron 'sensors' that inhibit ISC biosynthesis if the availability of iron exceeds the presence of downstream ISC apo-acceptors [3] . An extension of this negativeregulator model of frataxin function to haem biosynthesis would help explain the earlier observation that frataxin levels decline in concert with an increase in haem synthesis during erythroid differentiation of Friend cells [4] . It is also worth noting that a role for frataxins as iron sensors is consistent with their relatively low (i.e. micromolar) binding affinities for iron [3] . These results may indicate that frataxin levels are physiologically regulated to 'fine-tune' the quantity of metabolically available iron in the mitochondria to match that required by downstream metabolic processes in certain cell types.
Another intriguing, yet highly controversial, facet of frataxin behaviour is the self-assembly of frataxin oligomers. It appears that, under a set of somewhat strict and not necessarily physiological solution conditions, iron binding by frataxin (at least in the yeast and bacterial orthologues) can trigger frataxin oligomerization [1, 5] . In Yfh1, this oligomerization is associated with the development of an intrinsic ferroxidase activity that results in storage of mineralized ferric iron (in a similar manner to the iron-storage protein ferritin) within the oligomeric structure [1, 5] . This ferroxidase activity, which is apparently absent from the monomeric form, may be a 'detoxification' mechanism to protect cells from iron-mediated oxidative damage under conditions of excess mitochondrial iron [1] . An important caveat to this story, especially when considering the role of frataxin in FRDA, is that human frataxin only appears to show self-assembly behaviour when grossly overexpressed in Escherichia coli [1, 5] , casting doubt on the physiological relevance of oligomerization. Thus, although oligomerization of bacterial and yeast frataxin orthologues occurs in vitro, whether this oligomerization occurs in vivo, and whether it is relevant to human frataxin function, is not clear [5] .
Frataxins from bacteria, yeast and humans share a high degree of sequence identity and structural similarity. The basic frataxin structure consists of two α-helices at the N-and C-terminal ends of the protein that are flanked by an antiparallel β-sheet of five to seven strands in a 'sandwich' motif [1] . The apparent requirement for iron binding by frataxins is supported by the remarkable The iron-storage hypothesis is thought to help rationalize the observation that in the presence of excess labile iron, the yeast frataxin orthologue (Yfh1) is capable of self-assembling into oligomers and higher-order multimers that possess ferroxidase activity. These multimeric structures appear to be capable of storing iron in a mineralized ferric form. (B) It has also been proposed that Yfh1's oligomerization-dependent ferroxidase activity may contribute to protection from iron-mediated oxidative stress resulting from toxic reactive oxygen species (ROS) formed via Fenton chemistry [9] . (C) Some evidence suggests that frataxin may function as an iron chaperone or 'donor' in iron-dependent biosynthetic reactions such as ISC and haem biosynthesis. (D) An alternative, but related, hypothesis suggests that, rather than being an iron chaperone, frataxin may function as a metabolic 'switch' that results in the diversion of iron from one metabolic pathway (e.g. ISC biosynthesis) to another (e.g. haem biosynthesis) [4] . (E) A very recent suggestion is that the bacterial frataxin orthologue (CyaY) may function as a negative regulator that inhibits the rate of ISC biosynthesis if the availability of iron is high and the availability of downstream ISC apo-acceptors is low [3] . The veracity of this model remains to be demonstrated in eukaryotic systems.
conservation of acidic character in the putative iron-binding site [1] . This site consists of a patch of solvent-exposed glutamate and aspartate residues at the interface between the first helix and first strand, in a region termed the 'acidic ridge' [1] . Previous work with Yfh1 has demonstrated that the loss of acidic character (e.g. charge-to-neutral amino acid substitution) in this region impairs iron binding and, depending on the degree of this loss, can also impair ISC biosynthesis and increase oxidative stress in yeast expressing the mutant proteins [1, 6] .
In this issue of the Biochemical Journal, Correia et al. [7] have extended such studies by examining the effects of a loss of negative charge in the acidic ridge region of Yfh1 on yeast phenotype and frataxin structure. In particular, the authors have generated Yfh1 mutants affecting up to five of the semiconserved, negatively charged (i.e. aspartate/glutamate) residues in the acidic ridge, as well as several control mutants affecting residues 122-124 within the spatially distinct Isu-binding site [8] , located on the β-sheet surface. The experiments performed in this study can generally be divided into those that examined changes in Yfh1 function (i.e. growth support, mitochondrial ISC biosynthetic capacity, protein-protein interactions with Isu and iron-binding affinity) and structural stability/plasticity (i.e. thermal stability/resistance to trypsin degradation).
In the functional studies, changes in key residues in the acidic ridge or Isu-binding site only impair yeast growth under conditions of reduced expression (mirroring the reduced frataxin levels in FRDA) [8] . Importantly, this impairment of growth is mirrored by significant decreases in mitochondrial aconitase activity (even at normal expression levels), with changes in the Isu-binding site leading to a greater loss of aconitase activity than changes in the acidic ridge [7] . These results suggest, consistent with previous observations [6, 8] , that mutations in critical residues of both the acidic ridge and Isu-binding site ultimately affect ISC biosynthesis and/or repair within the mitochondrion.
When the authors examined differences in iron binding by the various Yfh1 mutants, they observed, consistent with an earlier report [9] , only modest decreases in iron-binding affinity and absolutely no change in iron-binding capacity (i.e. all mutants bound two atoms of iron per Yfh1) [7] . The authors suggest that these somewhat counterintuitive results point to the probable involvement of 'secondary' iron-binding sites within Yfh1 [7] . Some of these have previously been suggested by NMRdetectable iron-induced resonance shifts in certain residues in the vicinity of the acidic ridge [1] .
The authors further observe that changes in the Isu-binding site result in a similar decrease in iron-binding affinity to those in the acidic ridge, suggesting that the binding of Isu to Yfh1 may have 'long-range' effects on iron binding by the protein [7] . Conversely, the authors also observe that the interaction of Isu with Yfh1 does not occur in two of the acidic ridge mutants (at least in vitro), consistent with previous observations [6] . Thus the present results hint at the possibility that not only does iron binding to Yfh1 facilitate the interaction of Yfh1 with Isu, but also that the interaction of Yfh1 with Isu may itself affect the interaction of Yfh1 with iron. However, this possibility remains to be directly demonstrated by studies that examine the effect of Isu on the dissociation of iron bound to Yfh1.
The authors also examine the effect of alterations in the acidic ridge on Yfh1's structural stability and conformational plasticity [7] . Intriguingly, the results show that the loss of acidic character in the acidic ridge, but not alteration of the Isu-binding site, increases Yfh1's resistance to thermal denaturation (i.e. stability) and degradation by trypsin (i.e. conformational plasticity). The authors conclude that the acidic character of the 'primary' ironbinding site within the acidic ridge represents an evolutionary 'trade-off' that favours function (i.e. iron binding and interaction with Isu) over protein stability [7] . As suggested by the authors, the significance of this structure-function compromise may be to facilitate high-affinity binding of Yfh1 to its binding partners (e.g. Isu) [7] . This hypothesis is consistent with the notion that some degree of conformational flexibility in a protein's structure is invariably required for high-affinity protein-protein interactions. This could be important for frataxin's role as an iron chaperone ( Figure 1C ), metabolic 'switch' ( Figure 1D ) or iron sensor ( Figure 1E ). Indeed, it is well known that the formation of protein complexes (i.e. 'metabolons') to perform metabolic functions increases efficiency through substrate channelling and would thus help explain the high efficiency of iron utilization by the mitochondrion [4] . It would not be a surprise if, finally, frataxin is found to be a component of such a metabolon that is involved in the synthesis of ISCs and haem.
Although the present study provides further useful information that may allow greater understanding of frataxin function, several problems remain that must be addressed. First, while the interaction of iron with frataxin appears to be necessary for its function, the exact location(s) and specificity of the iron-binding site(s) remain unclear. For instance, although the acidic ridge is obviously involved in iron binding by frataxin, it is apparent that iron can be bound elsewhere (e.g. [10] and the study of Correia et al. [7] ). To explain this apparent lack of specificity, it is perhaps necessary to consider that iron binding to frataxin may not occur at distinct and invariant binding sites (e.g. as occurs in classical iron-binding proteins such as transferrin), but that the metal may be bound at various locations within a 'pool' of potential moderate-affinity binding sites within a broader anionic surface [10] . The use of any of these sites may be dictated and further stabilized by specific protein-protein interactions [10] and could be very useful if the molecule is playing a role as a chaperone or an iron sensor.
Secondly, what is the functional stoichiometry of iron binding by frataxin, and is it an important determinant of frataxin function? In yeast, the answer to the first part of this question could be 2, whereas in humans it appears to be 7. It is unclear whether this difference results in significant functional differences between human and yeast frataxins, as the human protein can apparently complement the loss of Yfh1 in the yeast system [11] . However, it is an important reminder of the requirement for great caution when extrapolating results obtained on frataxin behaviour from one species to another.
In summary, the study of Correia et al. [7] provides another piece of the puzzle in the mystery of frataxin function by demonstrating that the iron-binding behaviour of Yfh1 is likely to be linked to a structural flexibility of the protein that may be important for the downstream interactions with proteins involved in ISC biosynthesis. Further characterization of this behaviour in relation to mitochondrial iron metabolism and establishment of its conservation in human cells is now paramount.
